Kun-Yin Qiu
Overview
Explore the profile of Kun-Yin Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo S, Wang J, Fang J, Lei J, Wu X, Qiu K, et al.
Pediatr Blood Cancer
. 2024 Sep;
71(12):e31340.
PMID: 39334539
Purpose: Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a type of pediatric HLH that occurs frequently in Asia. Although immunochemotherapy based on etoposide and hormone has improved survival rates, there are...
2.
Qiu K, Liao X, Fang J, Zhou D
BMC Pediatr
. 2024 Sep;
24(1):574.
PMID: 39251964
Purpose: The current study aims to investigate the significance of N6-methyladenosine (mA) methylationrelated genes in the clinical prognosis of childhood relapsed B-cell acute lymphoblastic leukemia (B-ALLL) patient. Methods: Transcriptome data...
3.
Qiu K, Liao X, Huang K, Xu H, Li Y, Zhou D, et al.
Transl Cancer Res
. 2023 Nov;
12(10):2952-2958.
PMID: 37969368
Background: It is known that - is usually related to favorable prognosis, but aberration has been associated with poor prognosis among pediatric acute lymphoblastic leukemia (ALL). However, the outcome of...
4.
Liao X, Zhou D, Fang J, Qiu K
Transl Pediatr
. 2023 Jul;
12(6):1088-1097.
PMID: 37427069
Background: The childhood patients with mixed-lineage leukemia rearrangement (MLL-r) gene have worse outcome than non-MLL, and thus often treated with high-risk chemotherapy regimens, so targeted therapy is important for this...
5.
Qiu K, Liao X, Li Y, Huang K, Xu H, Fang J, et al.
BMC Cancer
. 2023 May;
23(1):476.
PMID: 37231380
Purpose: To explore the outcome and prognostic factors between inv(16) and t(8;21) disrupt core binding factor (CBF) in acute myeloid leukemia (AML). Methods: The clinical characteristic, probability of achieving complete...
6.
Qiu K, Wang J, Huang L, Li C, Xu L, Liu R, et al.
Am J Hematol
. 2023 Mar;
98(6):869-880.
PMID: 36877527
The efficacy and safety on the addition of vincristine (VCR) and dexamethasone (DEX) pulses to maintenance therapy among childhood acute lymphoblastic leukemia (ALL) remain uncertain. Herein, we perform an open-label,...
7.
Qiu K, Zhou D, Liao X, Huang K, Li Y, Xu H, et al.
BMC Cancer
. 2022 Dec;
22(1):1257.
PMID: 36461002
Purpose: To evaluate the prognostic factors and outcome for acute lymphoblastic leukemia (ALL) in children with MLL rearrangement (MLL-r). Methods: A total of 124 pediatric patients who were diagnosed with...
8.
Liu D, Hong W, Qiu K, Li X, Liu Y, Zhu L, et al.
Front Oncol
. 2022 Aug;
12:944248.
PMID: 35965561
Chimeric antigen receptor T (CAR-T) cell therapy is an effective treatment for relapsed and refractory acute lymphoblastic leukemia (R/R ALL). However, autologous CAR-T cells derived from patients with B-ALL often...
9.
Qiu K, Guo S, Zeng Y, Liao X, Lin S, Fang J, et al.
Hematology
. 2022 Aug;
27(1):874-880.
PMID: 35950974
Purpose Our aim is to analyze the clinical characteristics and prognostic factors of Epstein-Barr (EB) virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in children. Methods Children with newly diagnosed HLH were retrospectively analyzed....
10.
Qiu K, Liao X, Liu Y, Huang K, Li Y, Fang J, et al.
Nat Commun
. 2022 Jun;
13(1):3679.
PMID: 35760968
Activating FLT3 mutations are the most common mutations in acute myeloid leukemia (AML), but the optimal threshold of FLT3/ITD allelic ratio (AR) among pediatric AML patients remains controversial. Here, we...